Regulating the sale of human organs: A discussion in context with the global market

Current Opinion in Organ Transplantation

Volumn 13, Issue 2, 2008, Pages 196-201

  Surman, Owen S ^a   Saidi, Reza ^a   Burke, Thomas F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ethics; Human trafficking; Organs; Policy; Transplantation

Indexed keywords

BRAIN DEATH; CADAVER DONOR; CHINA; CRIME; ETHICS; GRAFT RECIPIENT; HUMAN; HUMAN RIGHTS; HUMAN TRAFFICKING; IRAN; LIVING DONOR; MARKET; ORGAN DONOR; POLICY; REVIEW; TISSUE ENGINEERING; TOURISM; WORLD HEALTH ORGANIZATION; XENOTRANSPLANTATION;

CHINA; COMMERCE; DEVELOPING COUNTRIES; HUMANS; IRAN; ORGAN TRANSPLANTATION; TISSUE DONORS; TRANSPLANTS; TRAVEL;

EID: 40649095730     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282f63c63     Document Type: Review

References (46)

1. Rothman SM, Rothman DJ. The hidden cost of organ sales. Am J Transplant 2006; 6:1524-1528. This paper reviews potential adverse social and political consequences of a regulated market in organ sales. The authors discuss risks of a 'crowding out effect' with regard to altruistic participation.
2. Simmerling M, Angelos P, Franklin J. Abecassis. The commercialization of human organs for transplantation: the current status of the ethical debate. Curr Opin Organ Transplant 2006; 11:130-135. This paper is an in-depth, well balanced review of ethical discourse regarding development of a regulated market for sale of human organs.
3. Burke TF. The global transaction of human organs: do no harm [abstract]. Xenotransplantation 2007; 14:392; Presented at the Joint Meeting of the International Xenotransplantation Association, the International Pancreas and Islet Transplant Association and the Cell Transplant Society, Minneapolis, Minnesota, 16 September 2007.
4. Garwood P. Dilemma over live-donor transplantation. Bull World Health Organ 2007; 85:5-6. This brief commentary provides authoritative documentation of the extensive reach of the global market in human organs.
5. Anonymous. Legal and illegal organ donation [editorial]. Lancet 2007, 369:1901. This report highlights efforts of the international community to increase knowledge about the workings of the global market in human organs.
6. Zarocostas J. UN calls for tougher rules to prevent sale of children's organs. BMJ 2007; 334:656. This news report underlines the WHO's growing concern about black market activity directed toward acquisition of paid organ from minors.
7. Scheper-Hughes N. The global traffic in human organs. Curr Anthropol 2000; 41:191-224.
8. Scheper-Hughes N. Parts unknown, undercover ethnography of the organstrafficking underworld. Ethnography 2004; 5:29-73.
9. Bakdash T, Scheper-Hughes N. Is it ethical for patients with renal disease to purchase kidneys from the world's poor? PLoS Med 2006; 3:e349. This report provides a view of coercion and suffering among the world's poor in face of predatory activity in the black market in human organs.
10. Goyal M, Mehta R, Schneiderman L, Sehgal A. Economic and health consequences of selling a kidney in India. JAMA 2002; 343:404-410.
11. Novelli G, Rossi M, Poli L, et al. Is legalizing the organ market possible? Transplant Proc 2007; 39:1743-1745. This report provides an informative overview of the global market in human organs as well as the authors' perspective about a regulated market.
12. Canales MT, Kaske BL, Rosenberg ME. Transplant tourism: outcomes of United States residents who undergo kidney transplantation overseas. Transplantation 2006; 82:1-9. This paper reviews clinical outcomes, including urgent medical complications, among 10 transplant recipients who returned to the USA for care after purchasing a kidney abroad.
13. Muraleedharan VR, Jan S, Prasad SR. The trade in human organs in Tamil Nadu: the anatomy of regulatory failure. Health Econ Policy Law 2005; 1:41-57.
14. Rakela J, Fung JJ. Liver transplantation in China [editorial]. Liver Transpl 2007; 13:182. This report presents an editorial perspective of China's practice of taking organs from felons at the time of execution. This is a companion piece to Huang's overview of organ transplantation in the PRC [19••].
15. Tibell A. The Transplantation Society's policy on interactions with China. Transplantation 2007; 84:292-294. This paper by the Chairman of the Ethics Committee of the Transplantation Society presents the group's China policy.
16. Matas A, Kilgour D. Report into allegations of organ harvesting of Falun Gong practitioners in China. David Kilgour: Edmonton, Alberta, Canada: 2006. http://www.david-kilgour.com/2006/Kilgour-Matas-organ-harvesting-rpt-July6-eng. pdf. [Accessed 4 February 2008] The authors report alleged human rights violations involving the Falun Gong religious sect in China.
17. Watts J. China introduces new rules to deter human organ trade. Lancet 2007; 369:1917-1918. This brief Lancet report documents recent governmental action by the PRC to illegalize the sale of human organs.
18. Beholz S, Kipke MA. The death penalty and organ transplantation in china: the role of academic heart surgeons. Heart Lung Transplant 2007; 26:873-875. This report describes the findings of thoracic surgeons who sought reliable source material about China's practice of taking organs from executed felons.
19. Huang J. Ethical and legislative perspectives on liver transplantation in the People's Republic of China. Liver Transpl 2007; 13:193-196. This is a significant perspective on transplantation in the PRC from one of the country's leading surgeons.
20. Satz D. Why should some things not be for sale? In: Cullenberg S, Pattanaik PK, editors. Globalization, culture and the limits of the market. Oxford, UK: Oxford University Press; 2004. pp. 10-37.
21. Kolnsberg HR. An economic study: should we sell human organs? Int J Soc Econ 2003; 30:1049-1069.
22. Kasserman DL. Should we sell human organs? Correction of a faulty analysis. Int J Soc Econ 2005; 32:893-898.
23. Kasserman DL. On the feasibility of resolving the organ shortage. Inquiry 2006; 43:160-166. This report details an econometric analysis favorable to the development of a regulated market for reimburesment for cadaver donor organs.
24. Byrne MM, Thompson P. A positive analysis of financial incentives for cadaveric organ donation. J Health Econ 2001; 20:69-83.
25. Haddow G. 'Because you're worth it?' The taking and selling of transplantable organs. J Med Ethics 2006; 32:324-328. This report presents the author's findings and impressions from a study in Scotland on the surveyed public sentiment about provision of incentives to increase the rate of cadaver organ donation.
26. Kittur DS, Hogan MM, Thukral VK, et al. Incentives for organ donation? For the United Network for Organ Sharing, Ad Hoc Donations Committee. Lancet 1991; 338:1441-1443.
27. Abadie A, Gay S. The impact of presumed consent legislation on cadaveric organ donation: a cross-country study. J Health Econ 2006; 25:599-620. This paper surveys availability of cadaver donor organs in 22 countries and quantifies the relative influence of presumed consent laws.
28. Shafer JS, Wagner D, Chessare J. Organ Donation Breakthrough Collaborative: increasing organ donation through system redesign. Crit Care Nurse 2006; 26:33-49. This paper reviews the organization and working model of the US Collaborative for encouragement of cadaver organ donation.
29. Howard DH, Siminoff LA, McBride V, et al. Does quality improvement work? Evaluation of the organ donation breakthrough collaborative. Health Surv Res 2007; 42:2160-2173. This paper reports findings from an outcome study of donation rates in 95 hospitals that participated in the US Collaborative's initial phase versus 125 hospitals that served as a control.
30. Vathsala A. Commercial renal transplantation: body parts for sale. Ann Acad Med Singapore 2006; 35:227-228. This author's report discusses bioethical considerations in a regulated market, as seen from the vantage point of a prominent transplantation professional in Singapore.
31. Freeman EA, Freeman AL. Payment for donor kidneys: pros and cons. Kidney Int 2006; 69:960-962. The authors discuss arguments in favor of a regulated market and discuss a possible financial model for its initiation.
32. Matas A. Why we should develop a regulated system of kidney sales. A call to action. Clin J Am Soc Nephrol 2006; 1:1129-1132. This paper is an in-depth argument in favor of a regulated market for human organs, as envisioned by the President of The American Association of Transplant Surgeons.
33. Hoyer PF. Commercial living nonrelated organ transplantation: a viewpoint from a developed country. Pediatr Nephrol 2006; 21:1364-1368. This paper presents a pediatric nephrologist's view of the challenge posed by the shortage of human organs and the perceived need by the poor to meet essential family health care needs through sale of organs.
34. Dew MA, Jacobs CL, Jowsey SG, et al. Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States. Am J Transplant 2007; 7:1047-1054. This paper on psychosocial evaluation of emotionally unrelated kidney donors documents the findings of a working group sponsored by United Network for Organ Sharing, The American Society of Transplant Surgeons, and The American Society of Transplantation.
35. Brennan T. Markets in healthcare: the case of renal transplantation. J Law Med Ethics 2007; 35:249-255. This paper, by the Medical Director of a major insurance company, provides a well informed economic perspective on anticipated future strain in the US healthcare system. The author favors government-funded acquisition and distribution of purchased organs.
36. Delmonico Fl, Arnold R, Scheper-Hughes N, et al. Ethical incentives - not payments - for organ donation. N Engl J Med 2002; 346:2002-2005.
37. ASTS and the University of Michigan Receive Grant, July 16, 2007 (http://www.asts.org/Tools/News.aspx?content_id=389). This report documents the Health Resources and Services Administration approved study of reimbursements for expenses incurred by living organ donors.
38. Surman OS, Saidi R, Purtilo R, et al. The market of human organs: a window into a poorly understood global business. Transplant Proc 2008 (in press).
39. Bagheri A. Compensated kidney donation: an ethical review of the Iranian model. Kennedy Inst Ethics J 2006; 15:269-282. This paper provides description of the Iranian market for human organ sales. The author favors compensation of expenses incurred by living organ donors.
40. Callahan D. Principilism and communitarianism. J Med Ethics 2003; 29:287-291.
41. Surman OS. Introduction and overview of symposium goals and process [abstract]. Xenotransplantation 2007; 14:392; Presented at the Joint Meeting of the International Xenotransplantation Association, the International Pancreas and Islet Transplant Association and the Cell Transplant Society, Minneapolic, Minnesota, 16 September 2007.
42. Purtilo R. Ethical consideration of transplantation policy: has every stone been turned? [abstract]. Xenotransplantation 2007; 14:393; Presented at the Joint Meeting of the International Xenotransplantation Association, the International Pancreas and Islet Transplant Association and the Cell Transplant Society, Minneapolic, Minnesota, 16 September 2007.
43. Cohen JJ, Cruess S, Davidson C. Alliance between society and medicine: the public's stake in medical professionalism. JAMA 2007; 298:670-671. This paper reviews fundamental obligations of organized medicine toward fulfillment of societal expectation.
44. Surman OS, Cosimi AB, Fukunishi I, et al. Some ethical and psychiatric aspects of fight-lobe liver transplantation in the United States and Japan. Psychosomatics 2002; 43:349-353.
45. Griffen A. Iranian organ donation: kidneys on demand. BMJ 2007; 334:502-505. This report presents a thorough, scholarly discussion of Iran's regulated market for living donor kidneys.
46. Malakoutian T, Hakemi MS, Nassiri AA, et al. Socioeconomic status of Iranian living unrelated kidney donors: a multicenter study. Transplant Proc 2007; 39:824-825. This report reviews the demographics of paid organ donors in the Iranian market.